Literature DB >> 8557389

Synergy of simultaneous administration of ofloxacin and granulocyte colony-stimulating factor in killing of Escherichia coli by human neutrophils.

A Kropec1, S W Lemmen, H J Grundmann, I Engels, F D Daschner.   

Abstract

The in vitro effect of subinhibitory and inhibitory concentrations of ofloxacin and G-CSF on the bactericidal activity of polymorphonuclear leucocytes (PMNL) against Escherichia coli was investigated. PMNL obtained from healthy volunteers were incubated with different concentrations of G-CSF and ofloxacin for 180 min. The minimum inhibitory concentration (MIC) of ofloxacin and even 1/4 x MIC enhanced the bactericidal activity of PMNL. G-CSF at a concentration of 6,000 units/ml led to a significant improvement of the bactericidal activity of PMNL. The combination of 6,000 units/ml of G-CSF and ofloxacin in inhibitory as well as subinhibitory concentrations, however, showed a significant synergistic effect on the antibacterial activity of PMNL during the complete incubation period. Combinations of G-CSF and antibiotics could therefore be beneficial for infected patients, especially those with impaired cellular host defense.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557389     DOI: 10.1007/bf01716290

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

Review 1.  Hematopoietic growth factors. Biology and clinical applications.

Authors:  J E Groopman; J M Molina; D T Scadden
Journal:  N Engl J Med       Date:  1989-11-23       Impact factor: 91.245

2.  Effect of combination therapy with recombinant human granulocyte colony-stimulating factor (rG-CSF) and antibiotics in neutropenic mice unresponsive to antibiotics alone.

Authors:  M Matsumoto; S Matsubara; T Yokota
Journal:  J Antimicrob Chemother       Date:  1991-09       Impact factor: 5.790

3.  Synergy of ceftazidime and human macrophages on phagocytosis and killing of Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  A M Cuffini; N A Carlone; L Xerri; M F Pizzoglio
Journal:  J Antimicrob Chemother       Date:  1987-08       Impact factor: 5.790

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Potentiation of phagocytosis of pathogenic bacteria by exposure to low concentrations of antibiotics.

Authors:  C G Gemmell
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

6.  Recombinant human granulocyte colony-stimulating factor enhances superoxide release in human granulocytes stimulated by the chemotactic peptide.

Authors:  S Kitagawa; A Yuo; L M Souza; M Saito; Y Miura; F Takaku
Journal:  Biochem Biophys Res Commun       Date:  1987-05-14       Impact factor: 3.575

7.  The beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with gentamicin on survival after Pseudomonas burn wound infection.

Authors:  G M Silver; R L Gamelli; M O'Reilly
Journal:  Surgery       Date:  1989-08       Impact factor: 3.982

8.  Effect of exogenous recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor on neutrophil function following allogeneic bone marrow transplantation.

Authors:  I Fabian; Y Kletter; I Bleiberg; M Gadish; E Naparsteck; S Slavin
Journal:  Exp Hematol       Date:  1991-10       Impact factor: 3.084

9.  Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils.

Authors:  E Roilides; T J Walsh; P A Pizzo; M Rubin
Journal:  J Infect Dis       Date:  1991-03       Impact factor: 5.226

Review 10.  Antimicrobial drugs, microorganisms, and phagocytes.

Authors:  P J van den Broek
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr
View more
  5 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  Synergism between poly-(1-6)-beta-D-glucopyranosyl-(1-3)-beta-D-glucopyranose glucan and cefazolin in prophylaxis of staphylococcal wound infection in a guinea pig model.

Authors:  A B Kaiser; D S Kernodle
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

4.  Effects of recombinant granulocyte-colony stimulating factor administration during Mycobacterium avium infection in mice.

Authors:  A S Gonçalves; R Appelberg
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

5.  Dependence of positive effects of granulocyte colony-stimulating factor on the antibiotic regimen: evaluation in rats with polymicrobial peritonitis.

Authors:  Artur Bauhofer; Alexander Torossian; Wilfried Lorenz; Martin Middeke; Ulrike Plaul; Philipp Schütz; Benno Stinner; Markus Hattel; Ilhan Celik
Journal:  World J Surg       Date:  2004-08-03       Impact factor: 3.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.